Polycythemia vera (PV) places patients in a difficult position: distinguishing between normal bodily changes and signs of disease progression. In the 2014 MPN Landmark survey, 78% of 380 U.S. patients with PV reported feeling anxious or worried about their condition. Some 60% of patients said they felt depressed, and 63% reported stress or anxiety related to keeping their hematocrit below 45%.
The first year after a PV diagnosis is often disorienting. Patients describe an experience where every physical sensation becomes a potential warning sign, even when test results remain stable. Adjusting to treatment side effects, work responsibilities, and lifestyle changes while avoiding emotional overload creates a unique strain. Patricia Pedreira, PhD, a licensed clinical psychologist specializing in psycho-oncology, notes that the mental strain of constant monitoring can become exhausting.
Uncertainty lies at the heart of this anxiety. Unlike conditions with predictable outcomes, PV’s progression risks—such as myelofibrosis or leukemia—are based on statistics rather than guarantees. Research published in the Blood Cancer Journal indicates that after 10 years, only 6% of patients develop myelofibrosis, and 2.3% progress to leukemia. After 15 years, the risk of myelofibrosis rises to roughly 14%, while the risk of leukemia remains around 5.5%.
Claire Brandon, MD, a dual board-certified psychiatrist specializing in medically complex care, explains that this unpredictability intensifies stress. “That is because we’re often waiting for the other shoe to drop,” she said. The term “cancer” itself triggers fear before patients fully grasp PV’s individual impact. Many assume worse outcomes than the data supports, confusing PV with more aggressive diseases.
This mismatch between perception and reality creates challenges. Dr. Pedreira emphasizes the importance of clear communication, presenting data without exaggeration to help patients focus on manageable aspects of care. “We don’t withhold information out of fear that patients can’t handle it. People are more capable than we often give them credit for,” she said. “The issue is how information is presented and translated.”
For those struggling with medical anxiety, structured coping strategies can provide relief. One effective method is setting aside a daily “worry time”, a specific period to address concerns methodically. Outside that time, patients learn to delay intrusive thoughts. Dr. Brandon describes this as training the brain to postpone anxiety until a scheduled moment, reducing its daily disruption.
Additional approaches include mindfulness exercises, regular physical activity, and limiting online symptom searches. Support groups and therapy designed for chronic illnesses can also offer perspective. Patients can’t prevent every anxious thought, but they can keep worry from taking over their day.
Beyond structured coping methods, peer support networks help normalize experiences. Many patients feel isolated when symptoms vary without clear explanations. Support groups, online or in person, share strategies for managing side effects like fatigue, itching, or joint pain, which can worsen anxiety when misunderstood.
Dr. Pedreira advises relying on structured updates from healthcare providers instead of unfiltered internet research. She suggests asking doctors to explain test results in straightforward terms, clarifying what specific values indicate stability versus concern. Clear communication shifts focus from hypothetical risks to actionable steps, such as adhering to treatment plans and attending regular check-ups.
